Washington, DC, United States of America

Irving William Wainer

USPTO Granted Patents = 19 (Patent Applications = 13)

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 31(Granted Patents)

Company Filing History:

17 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

The Cooper Health System

where one patent can have more than one assignee

Years Active: 2002-2023

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11827606 - Phenyl cyclohexanone derivatives and methods of making and using them (2023-11-28),

2. 11389415 - Methods of regulating cannabinoid receptor activity-related disorders and diseases (2022-07-19),

3. 11111210 - Phenyl cyclohexanone derivatives and methods of making and using them (2021-09-07),

4. 10925840 - Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas (2021-02-23),

5. 10772849 - Methods of regulating cannabinoid receptor activity-related disorders and diseases (2020-09-15),

6. 10617654 - Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas (2020-04-14),

7. 10562843 - Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure (2020-02-18),

8. 10485771 - Methods of regulating cannabinoid receptor activity-related disorders and diseases (2019-11-26),

9. 10308591 - Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure (2019-06-04),

10. 10130594 - Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas (2018-11-20),

11. 10130593 - Methods of regulating cannabinoid receptor activity-related disorders and diseases (2018-11-20),

12. 9908841 - Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure (2018-03-06),

13. 9867830 - Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain (2018-01-16),

14. 9650352 - Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain (2017-05-16),

15. 9522871 - [object Object] (2016-12-20),

Title: The Innovative Mind of Irving William Wainer

Introduction: Irving William Wainer, a pioneering inventor based in Washington, DC, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Irving William Wainer holds several patents in various technological domains, showcasing his continuous commitment to innovation and creativity.

Career Highlights: Throughout his illustrious career, Irving William Wainer has been at the forefront of technological advancements, revolutionizing industries with his inventive solutions. His work has not only garnered recognition but has also positively impacted the lives of many.

Collaborations: Irving William Wainer has collaborated with leading tech companies, research institutions, and universities to further his innovative projects. His ability to work in diverse teams has led to the development of cutting-edge technologies.

Conclusion: Irving William Wainer's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire future generations of inventors and shape the landscape of technological advancements.

This text is generated by artificial intelligence and may not be accurate.